Marie-Paule Kieny is a French virologist, vaccinologist, public health expert and science writer.

[1][9][10][11][12] Kieny even audaciously signed up herself as a test subject for the safety of new Ebola vaccines being developed, amidst concerns over the logistics and ethics of testing early-stage therapeutics and preventatives for ebola in the context of an ongoing epidemic.

[17] Kieny was involved also in addressing the ongoing antimicrobial resistance crisis with WHO, overseeing the first WHO Model List of Essential Medicines to include guidance on proper use of antibiotics within the framework of universal health care.

[22] In 2017 she joined the board of directors for the Human Vaccines Project, was made interim director of the Medicines Patent Pool (MPP), and joined the Drugs for Neglected Diseases Initiative (DNDi) as chief of the board.

[8][10][23][24][25] As head of MPP, Kieny oversaw the licensing of the Hepatitis C drug Mavyret for generic production.